Typicality: | 0.376 |
Saliency: | 0.295 |
currently | 3 | temporal |
to treat sma types | 2 | purpose |
around the world | 2 | location |
therapy → be approved in → the united states | 11 |
therapy → be approved in → the u.s. | 5 |
negative | neutral | positive |
0.027 | 0.669 | 0.304 |
Raw frequency | 16 |
Normalized frequency | 0.295 |
Modifier score | 0.500 |
Perplexity | 135.205 |